Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology EquipmentCell Culture

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1528102

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1528102

3D Cell Culture

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global 3D Cell Culture Market to Reach US$3.9 Billion by 2030

The global market for 3D Cell Culture estimated at US$1.6 Billion in the year 2023, is expected to reach US$3.9 Billion by 2030, growing at a CAGR of 13.9% over the analysis period 2023-2030. Scaffold-based 3D Cell Culture, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Scaffold-free 3D Cell Culture segment is estimated at 13.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$498.7 Million While China is Forecast to Grow at 14.9% CAGR

The 3D Cell Culture market in the U.S. is estimated at US$498.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$248.8 Million by the year 2030 trailing a CAGR of 14.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.5% and 12.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.4% CAGR.

Global 3D Cell Culture Market - Key Trends & Drivers Summarized

What Is 3D Cell Culture and Why Is It Revolutionizing Biomedical Research?

3D cell culture is a groundbreaking technique in biomedical research that allows cells to grow in a three-dimensional environment, closely mimicking the natural conditions of human tissues. Unlike traditional 2D cultures where cells are grown in flat dishes, 3D cell cultures enable cells to interact in all directions, which significantly influences their growth, function, and responsiveness to stimuli. This method provides a more accurate model for studying complex biological processes, testing pharmaceuticals, and understanding disease progression. Key applications include cancer research, where 3D cultures replicate tumor microenvironments more realistically, enhancing the predictive accuracy of how cancerous cells respond to treatments. This technology is also pivotal in tissue engineering, regenerative medicine, and stem cell research, offering new potentials for developing and testing medical treatments and therapies.

How Are Technological Advancements Enhancing 3D Cell Culture Techniques?

Technological advancements are significantly enhancing the capabilities of 3D cell culture systems. Innovations in scaffold materials and design are crucial, as these structures support the growth of cells by mimicking the extracellular matrix found in natural tissues. Biodegradable and biocompatible materials such as hydrogels, micropatterned surfaces, and nanofiber scaffolds are being developed to improve cell viability and function. Additionally, the integration of microfluidics technology with 3D cell cultures—the basis of organ-on-a-chip systems—enables the simulation of physiological conditions, such as blood flow, which are essential for creating accurate organ models. Advances in imaging and analytical techniques also allow researchers to observe and measure cellular processes in real-time within these complex 3D structures, providing deeper insights into cellular behaviors and drug responses without the need for invasive procedures.

What Impact Does 3D Cell Culture Have on Drug Development and Personalized Medicine?

3D cell culture's impact on drug development and personalized medicine is profound and multifaceted. In drug discovery, 3D models significantly reduce the reliance on animal testing, providing a more ethical and cost-effective method for screening potential drugs. The enhanced biological relevance of 3D cultures leads to better prediction of how drugs will perform in human trials, thus improving the efficiency of the development process and reducing the risk of late-stage failures. For personalized medicine, 3D cultures can be developed using cells extracted from individual patients, allowing researchers and clinicians to test how specific treatments might work on a case-by-case basis. This approach not only tailors therapies to individual genetic and biochemical backgrounds but also helps in identifying the most effective treatment strategies, minimizing side effects, and sparing patients from ineffective treatments.

What Drives the Growth of the 3D Cell Culture Market?

The growth in the 3D cell culture market is driven by several factors, including the escalating demand for more accurate and reliable drug screening methods and the rising need for personalized medicine solutions. Technological innovations that offer enhanced scalability, reproducibility, and automation of 3D culture systems are crucial in meeting these demands. Additionally, as the potential of 3D cell cultures in clinical applications becomes more evident, there is a growing interest from pharmaceutical companies and healthcare providers to invest in this technology. Consumer behavior, particularly the increasing public and regulatory pressure to reduce animal testing in pharmaceutical and cosmetic industries, also plays a significant role in driving the adoption of 3D cultures. Moreover, the expanding applications of 3D cell cultures in cancer research, stem cell therapy, and tissue engineering continue to spur the development of new products and techniques in this field. These factors, combined with ongoing academic and commercial research collaborations, ensure a dynamic and expanding market, poised to address some of the most challenging issues in medical research and patient care.

Select Competitors (Total 38 Featured) -

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • GE Healthcare
  • Corning, Inc.
  • Charles River Laboratories International, Inc.
  • BioTek Instruments, Inc.
  • F. Hoffmann-La Roche AG
  • AMS Biotechnology (Europe) Ltd. (amsbio)
  • BellBrook Labs
  • ABER Instruments Ltd.
  • Creative Biolabs
  • Elveflow
  • Emulate, Inc.
Show more
Product Code: MCP10010

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • 3D Cell Culture - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • 3D Cell Culture Transforms Life Sciences Industry
    • 3D Cell Culture: An Introduction
    • 3D-Cell Culture Models
    • Benefits of 3D Cell Culture
    • Key 3D Cell Culture Formats
    • 3D Cell Culture-Different Techniques
    • Scaffold-Based 3D Cell Culture
    • Polymeric Hard Scaffolds
    • Biological Scaffolds
    • Micropatterned Surface Microplates
    • Non-Scaffold Based 3D Cell Culture
    • Hanging Drop Microplates
    • Spheroid Microplates with Ultra-Low Attachment (ULA) coating
    • Microfluidic 3D Cell Culture
    • Expanding Applications Fuel Growth in the Global 3D Cell Culture Market
    • Developed Regions Lead the 3D Cell Culture Market, Asia-Pacific to Register Faster Growth
    • Scaffold-based 3D Cell Culture Products Dominate the Market
    • Cancer and Stem Cell Research Leads the Global Market
    • Competitive Scenario
    • Key Commercial 3D Cell Culture Devices
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cancer Drives the Demand for 3D Cell Culture
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Increasing Demand for 3D Cell Culture in Drug Discovery
    • Use of 3D Cell Culture for Regenerative Medicine
    • Organoids as Alternatives to Using Animals in Experiments
    • Use of 3D Cell Culture for Regenerative Medicine
    • Microfluidic Chips Hold Potential in Addressing 3D Cell Culture Challenges
    • Technological Advancements Promote 3D Cell Culture Market
    • Researchers Use Lab-on-a-CD Technology to Generate Spheroid 3D Cell Cultures
    • 3D Bioprinting Holds Potential to Revolutionize Organ Transplantation Space
    • A Review of Research Efforts and Achievements of Companies and Universities
    • 3D Tissue Culture: Growing Significance in Cancer Research
    • Cells Grown in 3D Change Cell Proliferation and Morphology
    • Cells Grown in 3D Demonstrate a More Pragmatic Drug Response
    • Cells Grown in 3D Express Phenotypic Heterogeneity
    • Cells Grown in 3D Alter Cell Behavior and Gene Expression
    • Cells Grown in 3D Replicate the Tumor Microenvironment
    • Other Advantages of 3D Tissue Culture Models
    • New Dimension of Cell Culture: The Rise of Spheroid Culture Systems
    • Challenges
    • Progress in Scaffolds and Hydrogels Aids Creation of Organoids and Spheroids
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for 3D Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for 3D Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 3: World 13-Year Perspective for 3D Cell Culture by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2017, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Scaffold-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Scaffold-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 6: World 13-Year Perspective for Scaffold-based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Scaffold-free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Scaffold-free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 9: World 13-Year Perspective for Scaffold-free by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Microfluidics-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Microfluidics-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 12: World 13-Year Perspective for Microfluidics-based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Magnetic & Bioprinted by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Magnetic & Bioprinted by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 15: World 13-Year Perspective for Magnetic & Bioprinted by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cancer & Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Cancer & Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 18: World 13-Year Perspective for Cancer & Stem Cell Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Drug Discovery & Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Drug Discovery & Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 21: World 13-Year Perspective for Drug Discovery & Toxicology Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Tissue Engineering & Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Tissue Engineering & Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 24: World 13-Year Perspective for Tissue Engineering & Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
    • TABLE 25: World 3D Cell Culture Market Analysis of Annual Sales in US$ Thousand for Years 2017 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 28: USA 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 31: USA 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 34: Canada 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 37: Canada 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • JAPAN
    • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 40: Japan 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 43: Japan 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • CHINA
    • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 46: China 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 49: China 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • EUROPE
    • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for 3D Cell Culture by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for 3D Cell Culture by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 52: Europe 13-Year Perspective for 3D Cell Culture by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2017, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 55: Europe 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 58: Europe 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • FRANCE
    • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 61: France 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 64: France 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • GERMANY
    • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 67: Germany 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 70: Germany 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 73: Italy 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 76: Italy 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • UNITED KINGDOM
    • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 79: UK 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 82: UK 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • ASIA-PACIFIC
    • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 97: Rest of World 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
    • TABLE 100: Rest of World 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!